A recent study points out the importance of breast cancer physicians and pathologists working together to evaluate breast biopsies to arrive at the most accurate diagnosis.
Single-dose intraoperative radiation therapy for early-stage breast cancer reduces exposure to healthy tissue and significantly reduces treatment time. How is it being used in North America, and how are patients faring? Cleveland Clinic is leading a retrospective study to find out.
Although uncommon in younger women, breast cancer poses unique medical and lifestyle challenges for this group. Cleveland Clinic has begun a Young Women’s Breast Cancer Clinic to coordinate care and address specific needs of patients younger than 50.
Leading researchers recently gathered at Cleveland Clinic to review promising developments in breast cancer treatment, including new drugs for HER2+ and ER+ metastatic disease and preserving fertility during chemotherapy.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Adjuvant therapies and genetics research for breast cancer dominated recent oncology meetings. Key studies, summarized by Cleveland Clinic’s Jame Abraham, MD in The ASCO Post, should lead to better treatment.
Cleveland Clinic’s multidisciplinary approach to cancer care is demonstrated in the new Tumor Board webcast video series. The series launches with an HER2-positive breast cancer case.
This 37-year-old woman’s case illustrates the value of a multidisciplinary spine tumor board when metastatic breast cancer first manifests as back pain.
A unique trial will test the combination of two powerful and targeted breast cancer drugs, determining their safety and tolerability in Phase I and the overall response rate in Phase II.
Clinical trial compares chemotherapy schedules in high-risk early-stage breast cancer.
Researchers at Cleveland Clinic are participating in a multicenter study of CDX-011 for triple negative breast cancer.